Mayne Pharma Group Limited

Sümbol: MYX.AX

ASX

6.8

AUD

Turuhind täna

-2.3865
P/E suhe
-0.0091
PEG suhe
578.51M
MRK Cap
0.00%
DIV tootlus

Mayne Pharma Group Limited (MYX-AX) Finantsaruanded

Q: Mis on Mayne Pharma Group Limited (MYX.AX) koguvara?

Mayne Pharma Group Limited (MYX.AX) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Mayne Pharma Group Limited (MYX.AX) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Mayne Pharma Group Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008
balance-sheet.row.cash-and-short-term-investments	229.2	97.1	98.4	138.2	89.6	102.4	70.7	50.4	60.5	15.2	20.8	11.6	5.8	19.7	7.9	11.5	15.3
balance-sheet.row.short-term-investments	127.5	1.3	0	0	0.6	8.3	6.2	2.9	1.3	0.4	1.8	0	0	0	0	0	0
balance-sheet.row.net-receivables	209.5	283	193.3	233.3	251	251.7	223.6	91.7	63.1	29.2	24.6	3.8	5.7	6	0	0	0.1
balance-sheet.row.inventory	82.7	108.9	102.5	94	100.3	82.2	106.4	38.9	22.4	17.2	13.6	7.2	6.4	6.5	0	0	0
balance-sheet.row.other-current-assets	32.2	22.6	22.3	25.5	31	51.3	22.9	896	10.8	4.2	1.3	0.6	0.3	0.3	0	0.1	0.1
balance-sheet.row.total-current-assets	553.6	511.6	416.5	490.9	471.9	480.8	422.1	1077.1	156.8	65.9	61.9	23.3	18.8	32.5	8	11.6	15.5
balance-sheet.row.property-plant-equipment-net	51.5	225.9	221.6	238.2	236	230.1	189.3	84.4	59.6	53.4	55	22.2	21.5	21	0	0	0.1
balance-sheet.row.goodwill	0	22.1	20.3	22.2	21.7	20.6	58.2	60.1	58.4	47.5	47.2	0.4	0.4	0.4	0	0	0
balance-sheet.row.intangible-assets	617.3	427.5	636.2	962.3	722.5	931.7	1085.6	200.3	193	60.2	68.3	4.2	8.2	14.2	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	617.3	449.6	656.5	984.5	744.3	952.3	1143.8	260.4	251.4	107.7	115.5	4.2	8.2	14.2	0	0	0
balance-sheet.row.long-term-investments	0	-22.1	-20.3	1137.7	830.4	1102	1252.4	295.2	301.4	4.1	152.5	0	0	0	0	0	0
balance-sheet.row.tax-assets	23.4	133.7	187.2	150.7	149.9	80.4	80.7	49.6	9.6	1.3	1	4.3	5.2	3.3	0	0	0
balance-sheet.row.other-non-current-assets	2.3	4.5	16.7	-1159.8	-980.3	-1182.4	-80.7	-49.6	-9.6	-1.3	0	0	0	0	0	0	0
balance-sheet.row.total-non-current-assets	694.5	791.5	1061.6	1351.3	980.3	1182.4	1333.1	344.9	311	165.2	171.5	30.7	34.8	38.6	0	0	0.1
balance-sheet.row.other-assets	0	0	0	0	183.5	167.4	152.8	103.8	61.1	34.8	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1248.1	1303.1	1478.1	1842.2	1635.7	1830.5	1908	1525.8	528.9	265.8	233.4	53.9	53.7	71.1	8	11.7	15.5
balance-sheet.row.account-payables	32	63.6	42.4	29.8	50.4	63.9	66.6	64.1	51.6	7.1	10.5	4.2	3.8	3.9	0.2	0.2	1
balance-sheet.row.short-term-debt	14.4	408	54	44.8	50.9	0.1	13.1	0.5	0	2.4	7.5	0	2.3	7.6	0	0	0
balance-sheet.row.tax-payables	0	1.2	0	0	0	0	0	12.3	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	28.5	5.7	285.8	344.4	318.5	374.1	327	76.2	60.8	45.7	39.2	0	0	1	0	0	0
Deferred Revenue Non Current	4.6	0	7	8.8	267.4	324.8	250.7	16.7	19.4	23.9	0.8	0	0	1.5	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	256.9	156.9	125.9	143.6	108.1	116.8	113.3	959.8	43.5	20.9	18.1	8.1	5.8	6.5	0	0	0
balance-sheet.row.total-non-current-liabilities	302.8	135.6	484	580.7	318.5	374.1	327	76.2	60.8	45.7	70.4	11	14.6	22.4	0	0	0
balance-sheet.row.other-liabilities	0	0	0	0	92.4	40.5	75.6	49.1	50.9	30.5	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	4.6	5.7	7	8.8	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	613.8	764.9	706.6	799.9	622.3	595.4	595.6	1149.6	206.7	106.5	112.5	23.3	29.5	45.6	0.3	0.3	1
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1233.7	1238.5	1238.5	1238.6	1140	1131.8	1130.4	263.2	255.8	137.5	118.3	32	31.9	29.6	15.9	15.9	15.9
balance-sheet.row.retained-earnings	-769.8	-840.3	-559.1	-350.6	-257.9	23.5	150.1	61.5	24.2	16.4	-4.9	-2.5	-8.7	-5.8	-9.1	-5.3	-1.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	170.4	147.7	88.9	149.6	125	71.2	23.3	39.1	30.9	5.4	7.5	1.1	1	1.7	0.9	0.9	0.4
balance-sheet.row.other-total-stockholders-equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-stockholders-equity	634.4	545.9	768.4	1037.5	1007.2	1226.5	1303.8	363.7	310.9	159.3	120.9	30.6	24.2	25.5	7.7	11.4	14.5
balance-sheet.row.total-liabilities-and-stockholders-equity	1248.1	1303.1	1478.1	1842.2	1655.5	1845.7	1927.5	1543.6	528.9	265.8	233.4	53.9	53.7	71.1	8	11.7	15.5
balance-sheet.row.minority-interest	0	-7.7	3.2	4.8	6.3	8.7	8.6	12.5	11.3	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	634.4	538.2	771.6	1042.3	1013.5	1235.2	1312.4	376.2	322.2	159.3	120.9	30.6	24.2	25.5	7.7	11.4	14.5
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	127.5	1.3	-20.3	1137.7	0.6	8.3	6.2	2.9	1.3	4.5	1.8	0	0	0	0	0	0
balance-sheet.row.total-debt	47.5	413.7	346.8	398	369.4	374.2	340.2	76.8	61.8	48	46.7	0	2.3	8.6	0	0	0
balance-sheet.row.net-debt	-54.2	316.6	248.5	259.9	280.4	286.9	277.2	29.4	2.6	33.2	27.8	-11.6	-3.5	-11.1	-7.9	-11.5	-15.3

Rahavoogude aruanne

Mayne Pharma Group Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008
cash-flows.row.net-income	-317.4	-209.5	-208.4	-92.8	-279.2	-134	88.6	37.4	7.8	21.3	-2.8	6.2	1.7	3.3	-3.8	-3.5	-1.8
cash-flows.row.depreciation-and-amortization	65.4	55.2	68.2	84.6	89.4	76.4	70.4	20.2	13.1	9.7	3.7	3.8	6.1	6.6	0	0	0
cash-flows.row.deferred-income-tax	50	63.4	-43.9	-42.6	-50.6	-0.2	-32.6	-25.7	30.9	6	6.1	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	6.8	4.6	7.7	7	9	14.5	11.2	5.1	1.8	1.4	0.7	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	145.4	-8.9	-13.6	50.2	3	-0.7	-225.8	-42.9	-32.7	-7.4	-6.8	0	0	0	0	0	0
cash-flows.row.account-receivables	118.7	-66.1	-3.2	67.5	9.4	-17.8	-146.1	-26.3	-30.3	-4	-5.5	0	0	0	0	0	0
cash-flows.row.inventory	-12.1	-2.4	-25.9	13.1	-6.4	17.1	-79.7	-16.7	-2.5	-3.4	-1.3	0	0	0	0	0	0
cash-flows.row.account-payables	45.3	60.7	16.4	-26.3	-30	10.1	35.9	51.4	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-6.5	-1.1	-0.9	-4.1	30	-10.1	-35.9	-51.4	0	0	0	0	0	0	0	0	0
cash-flows.row.other-non-cash-items	6.6	78.6	237.3	93.5	335	165.4	73	59.5	32.5	1.2	12.1	3.4	-3.7	0.4	0.1	0.4	0.6
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-219.6	-11.9	-25.1	-47.1	-11.9	-54.2	-104.4	-29.6	-4.2	-4.2	-21.1	-2.5	-2.1	-0.4	0	0	-0.1
cash-flows.row.acquisitions-net	842.2	5.2	0	0	0	-0.2	0.8	0	1	-0.8	-103.1	0	0	-18.4	0	0	0
cash-flows.row.purchases-of-investments	-127.5	0	0	0	-0.5	-0.5	0	0	-1	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-21.6	-21.8	-24.1	-8.8	-79.3	-64.2	-994.2	-54.2	-91.4	-45.8	-1.3	0	0	0	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	473.5	-28.5	-49.2	-55.9	-91.7	-118.3	-1097.8	-83.8	-95.5	-50.8	-125.5	-2.5	-2.1	-18.8	0	0	-0.1
cash-flows.row.debt-repayment	-376	-39.8	-25.8	-8.3	-62.5	-0.1	-0.5	-0.3	-59.7	-6.4	-1.1	-2.3	-5.1	-2.7	0	0	0
cash-flows.row.common-stock-issued	2.3	0	0	0.1	7.1	1.5	863.8	4.7	118.6	18.1	89.6	0	1.5	14.2	0	0	16.9
cash-flows.row.common-stock-repurchased	-6.2	0	0	0	0	0	-4.8	0	-4.6	-0.7	-4	0	0	-0.8	0	-0.7	-0.3
cash-flows.row.dividends-paid	-45.3	0	0	0	0	0	-858.5	0	-54.3	-11.1	-45.7	0	-4.5	-10.7	0	0	0
cash-flows.row.other-financing-activites	-6.2	76.8	-3	12.8	39.9	18.8	271.2	13.7	60.8	8.8	87.4	-2.9	-6.6	20.4	0	0	0
cash-flows.row.net-cash-used-provided-by-financing-activities	-431.5	37	-28.8	4.5	-15.6	20.2	1129.7	18	115.1	19.9	126.2	-5.2	-14.7	20.3	0	-0.7	16.6
cash-flows.row.effect-of-forex-changes-on-cash	-2.9	6.8	-9	0.4	2.3	1	-1.1	0.6	2.4	-0.2	1	0.1	-1.2	0	0	0	0
cash-flows.row.net-change-in-cash	4.6	-1.3	-39.8	48.8	1.7	24.3	15.2	-11.7	44.5	-5	7.3	5.8	-13.9	11.8	-3.6	-3.8	15.3
cash-flows.row.cash-at-end-of-period	101.7	97.1	98.4	138.2	89	87.3	63	47.9	59.6	15.1	18.9	11.6	5.8	19.7	7.9	11.5	15.3
cash-flows.row.cash-at-beginning-of-period	97.1	98.4	138.2	89.4	87.3	63	47.9	59.6	15.1	20.1	11.6	5.8	19.7	7.9	11.5	15.3	0
cash-flows.row.operating-cash-flow	-43.1	-16.6	47.3	99.8	106.6	121.5	-15.2	53.5	22.4	26.1	6.8	13.4	4.1	10.3	-3.6	-3	-1.2
cash-flows.row.capital-expenditure	-219.6	-11.9	-25.1	-47.1	-11.9	-54.2	-104.4	-29.6	-4.2	-4.2	-21.1	-2.5	-2.1	-0.4	0	0	-0.1
cash-flows.row.free-cash-flow	-262.7	-28.5	22.2	52.7	94.7	67.3	-119.7	23.9	18.2	21.9	-14.2	10.8	2	9.9	-3.6	-3	-1.3

Kasumiaruande rida

Mayne Pharma Group Limited tulud muutusid võrreldes eelmise perioodiga NaN%. MYX.AX brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008
income-statement-row.row.total-revenue	183.6	157.1	400.8	457	525.2	530.3	572.6	267.3	140.3	142.2	82.3	51.1	48.8	37	1	0.8	0.1
income-statement-row.row.cost-of-revenue	156.7	133.4	273.8	316	316.2	346.1	324	115.2	61.4	68.2	44.4	29.3	26.9	19.1	0	0	0
income-statement-row.row.gross-profit	26.8	23.7	127	140.9	209	184.2	248.6	152	78.9	74	37.8	21.7	21.9	17.9	1	0.8	0.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	12.6	74.4	6.4	15.4	-7.9	4.7	27.5	-1.3	4	3.6	-8.4	4.3	2.1	-0.3	0.6	-0.1	0
income-statement-row.row.operating-expenses	213.3	145.6	125.7	153.1	179.9	147.1	126.3	96.5	70	50.3	31.9	17.3	21.6	15.5	5.2	4.3	2
income-statement-row.row.cost-and-expenses	370	279	399.4	469.1	496	493.2	450.3	211.8	131.5	118.5	76.3	48.4	49.3	34.6	5.2	4.3	2
income-statement-row.row.interest-income	6.7	0.5	0.7	0.8	1	0.1	0.3	0.5	0.4	0.3	0.4	0.2	0.3	0.2	0.4	0.8	0.1
income-statement-row.row.interest-expense	10.5	11.5	13.3	16.8	18.1	15.8	11.5	2.5	5.9	4.3	2.3	0	1.8	1.5	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-83.3	-23.7	-265.3	-123.2	-382.9	-203.9	-6.3	-5.7	3	3.6	-8.4	3.3	0	-0.3	0.6	-0.1	0.1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	12.6	74.4	6.4	15.4	-7.9	4.7	27.5	-1.3	4	3.6	-8.4	4.3	2.1	-0.3	0.6	-0.1	0
income-statement-row.row.total-operating-expenses	-83.3	-23.7	-265.3	-123.2	-382.9	-203.9	-6.3	-5.7	3	3.6	-8.4	3.3	0	-0.3	0.6	-0.1	0.1
income-statement-row.row.interest-expense	10.5	11.5	13.3	16.8	18.1	15.8	11.5	2.5	5.9	4.3	2.3	0	1.8	1.5	0	0	0
income-statement-row.row.depreciation-and-amortization	65.4	55.2	68.2	84.6	94.5	79.9	73.7	21.4	13.5	9.9	7.4	3.8	6.1	5.3	0	0	0
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-186.4	-121.9	1.4	-12.1	29.2	37.1	122.3	55.5	17.2	32.4	6	2.5	-0.8	0.8	-5.2	-4.2	-2
income-statement-row.row.income-before-tax	-269.7	-145.6	-263.9	-135.4	-353.7	-166.8	115.9	49.8	11.2	28	-0.7	7.8	-1.5	0.6	-4.1	-3.5	-1.8
income-statement-row.row.income-tax-expense	47.7	74.5	-54.8	-40.8	-71.6	-32.5	29.9	15.3	3.7	6.7	2.1	1.6	-3.2	-2.6	-0.4	-0.1	0.1
income-statement-row.row.net-income	-316.4	-281.3	-208.4	-92.8	-279.2	-134	88.6	37.4	7.8	21.3	-2.8	6.2	1.7	3.3	-3.8	-3.5	-1.8